Compounds > xanthenes
Page last updated: 2024-08-18

xanthenes and phenobarbital sodium

xanthenes has been researched along with phenobarbital sodium in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, Z; Lin, S; Rhodes, PG1
Daniel, WA; Kos, T; Kozela, E; Popik, P; Slusher, BS; Wojcikowski, J; Wozniak, KM; Wrobel, M1
Alexander, GM; Godwin, DW1
Ahn, G; Bing, SJ; Cho, IH; Cho, J; Ha, D; Herath, KH; Jee, Y; Jo, SA; Kim, A; Kim, J; Yu, HS1
Cannella, LA; Gregg, RA; Hicks, C; Nayak, SU; Rawls, SM; Reitz, AB; Schena, GJ; Smith, GR; Tallarida, CS1

Other Studies

5 other study(ies) available for xanthenes and phenobarbital sodium

ArticleYear
Neuroprotective effects of N-acetylaspartylglutamate in a neonatal rat model of hypoxia-ischemia.
    European journal of pharmacology, 2002, Feb-22, Volume: 437, Issue:3

    Topics: Amino Acids; Animals; Animals, Newborn; Brain; Carboxypeptidases; Cyclic AMP; Cycloleucine; Dipeptides; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Glutamate Carboxypeptidase II; Hippocampus; Hypoxia-Ischemia, Brain; Neurons; Neuroprotective Agents; Organophosphorus Compounds; Propionates; Rats; Rats, Sprague-Dawley; Xanthenes

2002
2-MPPA, a selective glutamate carboxypeptidase II inhibitor, attenuates morphine tolerance but not dependence in C57/Bl mice.
    Psychopharmacology, 2005, Volume: 183, Issue:3

    Topics: Amino Acids; Animals; Drug Tolerance; Enzyme Inhibitors; Glutamate Carboxypeptidase II; Male; Mice; Mice, Inbred C57BL; Morphine; Morphine Dependence; Naloxone; Organophosphorus Compounds; Receptors, Metabotropic Glutamate; Xanthenes

2005
Unique presynaptic and postsynaptic roles of Group II metabotropic glutamate receptors in the modulation of thalamic network activity.
    Neuroscience, 2006, Aug-11, Volume: 141, Issue:1

    Topics: Amino Acids; Animals; Animals, Newborn; Bridged Bicyclo Compounds, Heterocyclic; Drug Interactions; Electric Stimulation; Excitatory Postsynaptic Potentials; Female; Ferrets; Gluconates; Guanosine Diphosphate; In Vitro Techniques; Male; Membrane Potentials; Nerve Net; Neurons; Organophosphorus Compounds; Patch-Clamp Techniques; Picrotoxin; Receptors, Metabotropic Glutamate; Synapses; Thalamus; Thionucleotides; Xanthenes

2006
Blocking glutamate carboxypeptidase II inhibits glutamate excitotoxicity and regulates immune responses in experimental autoimmune encephalomyelitis.
    The FEBS journal, 2016, Volume: 283, Issue:18

    Topics: Amino Acids; Animals; Astrocytes; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Antagonists; Female; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Immunohistochemistry; Mice; Mice, Inbred C57BL; Organophosphorus Compounds; Protease Inhibitors; Rats, Inbred Lew; Receptors, Metabotropic Glutamate; Spinal Cord; Th1 Cells; Xanthenes

2016
Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG).
    Psychopharmacology, 2017, Volume: 234, Issue:11

    Topics: Alkaloids; Amino Acids; Animals; Benzodioxoles; Conditioning, Psychological; Dipeptides; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glutamate Carboxypeptidase II; Male; Organophosphorus Compounds; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Reward; Synthetic Cathinone; Xanthenes

2017